John Vissing

Centre De Référence De Pathologie Neuromusculaire Paris Est,

Expertise in

conditions

Centre De Référence De Pathologie Neuromusculaire Paris Est,

Overview

John Vissing practices practicing medicine in Estonia.

Mr. Vissing is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Limb-Girdle Muscular Dystrophy, Myasthenia Gravis, Limb-Girdle Muscular Dystrophy Type 2I, and Pompe Disease.

He is actively involved in clinical research, co-authoring 395 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Centre De Référence De Pathologie Neuromusculaire Paris Est, Estonia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 24 Weeks Treatment With REN001 in Patients With Primary Mitochondrial Myopathy

Enrollment Status: Completed

Publish Date: May 08, 2024

Intervention Type: Drug

Study Drug: REN001

Study Phase: Phase 2

A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)

Enrollment Status: Unknown

Publish Date: April 03, 2024

Intervention Type: Drug

Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol

Study Phase: Phase 3

A Multicenter Open-Label Study on the Safety and Efficacy of Deflazacort (Emflaza) in Subjects With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)

Enrollment Status: Terminated

Publish Date: June 27, 2022

Intervention Type: Drug

Study Phase: Phase 3

View 2 Less Clinical Trials

395 Total Publications

Clinical, histopathological, and biomarker characterization of XLMTM and ADCNM: Operational lessons, screening and baseline data of the Unite-CNM study.

Journal: Journal of neuromuscular diseases

Published: August 14, 2026

View All 395 Publications

Frequently Asked Questions about John Vissing

Is John Vissing a top-rated expert for Limb-Girdle Muscular Dystrophy?

MediFind is an objective health platform that identifies experts based on real-world data. John Vissing is classified as an Elite expert for Limb-Girdle Muscular Dystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does John Vissing participate in research or clinical trials?

Yes. John Vissing has published 395 articles and abstracts on conditions like Limb-Girdle Muscular Dystrophy. You can view a list of John Vissing's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vissing's expertise for a condition

ConditionClose